The Buzz

All markets and investing news all the time

Forget the lottery. Invest in billionaire ETF?

April 2, 2014: 10:51 AM ET
ibillionaire app

The iBillionaire app launched in 2013. Now the company wants to launch an ETF based on legendary investors' picks.

If finance had a hall of fame, Warren Buffett, Carl Icahn, John Paulson, George Soros and Bill Ackman would probably be in it.

These men aren't just rich, they've managed to beat the market consistently.

Plenty of investors dream of being in their league, but decoding the market on your own is tough and buying into many of these famed investors' funds is steep.

While you can purchase a class B share of Buffett's Berkshire Hathaway (BRKB) for about $125, the A shares (BRKA) trade for a whopping $187,000. Paulson and Ackman run hedge funds that cater to wealthy investors only.

So what's someone without millions, let alone billions, to do?

One option may be the iBillionaire ETF that's set to launch in June. It's currently awaiting SEC approval.

"Most retail investors don't have a million or more to invest in all these hedge funds we are tracking. So really what the ETF is about is giving retail investors access to products they didn't have access to," Raul Moreno, CEO and co-founder of iBillionaire, told CNNMoney.

Moreno's company launched the iBillionaire app, which tracks the stock holdings of 21 billionaires, last year.

Users simply click on the name and photo of any titan and their stock portfolios come up along with data on how large each position is.

Investors can use the app to get ideas and to see how their portfolios compare to those of the financial stars. It's easy to use, and 85,000 people have downloaded it, according to the company.

The goal of the ETF is the combine the wisdom of the great investors.

Related: Buy a Warren Buffett Fathead for $29.99

The ETF will track the iBillionaire Index, a portfolio of the top 30 US large cap stocks these billionaires hold. The index averages the positions of 10 of the billionaires, including Buffett, who were selected because their portfolios don't turn over often and only contain large American companies.

Apple (AAPL), Wells Fargo (WFC) and Coca-Cola (KO) are the three largest holdings. They collectively make up more than 22% of the index.

One of the criticisms of this approach is that the index doesn't update frequently. Many hedge funds trade stocks on a daily basis, for instance, while the iBillionaire index updates only quarterly.

"We are looking only at investors not trading frequently. We're really targeting long-term investors," Moreno says.

So assuming the ETF gets the SEC's blessing, does it make sense as an investment for you?

Related: Soros betting against stocks? Not likely

Ben Johnson, director of passive fund research at Morningstar, warned that "it's a tall task when it comes to cutting through all of the marketing hype and unearthing whether or not there's actually any real economic intuition or investment merit" to some of these more gimmicky ETFs.

But the iBillionaire index has a decent track record. It has outperformed the S&P 500 over a one and three year time frame, but it is lagging the S&P 500 in 2014.

Still, there are similar investments currently on the market such as the Global X Guru Index ETF (GURU), which tracks the holdings of prominent hedge funds.

You could also argue that since the billionaires aren't really buying anything that unconventional, an investor might be better off with a standard index fund, like the SPDR S&P 500 ETF (SPY).

Related: Why Bill Ackman's bet against Herbalife could fail

Johnson notes there's been heated competition in the ETF field in recent years. Investment firms were "throwing anything against the wall" to see what stuck. The upside is that all the competition drove down fees.

The iBillionaire ETF, for example, will have an annual expense ratio cost of just 0.65%. That works out to $6.50 in fees for every $1,000 you invest. That's slightly lower than what the Guru ETF charges. And it's much lower than a hedge fund's fees.

  • Nu Skin surges as China's regulators barely rap knuckles

    Shares of Nu Skin (NUS) surged nearly 20% Monday after China announced a minimal fine to the skin care sales and marketing company. Investors had feared a far worse punishment. Shares of fellow multi-level marketer Herbalife (HLF) are up as well as investors shrug off hedge fund honcho Bill Ackman's concerns about similar sales violations.

    China's Administration of Industry and Commerce is penalizing Nu Skin only $781,000.  The slap on the wrist breaks MORE

    - Mar 24, 2014 12:34 PM ET
  • Herbalife tumbles on FTC probe

    Shares of Herbalife dropped more than 8% Wednesday after the nutritional products distributor revealed that was being investigated by the Federal Trade Commission. Trading of the stock was briefly halted prior to the announcement.

    "Herbalife welcomes the inquiry given the tremendous amount of misinformation in the marketplace," the company said in a statement. "Herbalife is a financially strong and successful company, having created meaningful value for shareholders, significant opportunities for distributors MORE

    - Mar 12, 2014 2:53 PM ET
  • Ackman to take Herbalife war to China

    Bill Ackman has said he will go "to the end of the earth" to bring down Herbalife. Tomorrow, he will take the fight to China.

    The hedge fund billionaire plans to unveil new evidence Tuesday that he says shows Herbalife (HLF), which sells nutritional supplements through a network of independent distributors, is operating in violation of Chinese law.

    Pershing Square Capital Management, Ackman's $11 billion hedge fund, will release a report showing MORE

    - Mar 10, 2014 11:53 AM ET
  • Boo! J.C. Penney is a scary stock

    The opinions expressed in this commentary are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney, Abbott Laboratories and AbbVie, La Monica does not own positions in any individual stocks.

    Want to really freak out a trader this Halloween? Go dressed as former J.C. Penney (JCP) CEO Ron Johnson. Or former board member/big shareholder Bill Ackman. Aaaagggh!

    J.C. Penney's stock performance this year is infinitely more MORE

    - Oct 31, 2013 1:27 PM ET
  • Bill Ackman rides the crazy train

    The opinions expressed in this commentary are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney, Abbott Laboratories and AbbVie, La Monica does not own positions in any individual stocks.

    Hedge fund manager Bill Ackman is having a rough year. But don't shed too many tears for him ... not that you probably would anyway, given that he's a billionaire and all.

    Yes, Ackman's Herbalife (HLF) MORE

    - Aug 13, 2013 12:57 PM ET
  • Ackman: P&G CEO may need to go

    Bill Ackman, the activist hedge fund manager who most recently made headlines over his big short position on Herbalife, zeroed in on Procter & Gamble at the Sohn Investment Conference in New York Wednesday.

    The CEO of Procter & Gamble (PG) is one busy man, but that doesn't mean he's solely focused on his work at the helm of one of the world's largest corporations.

    Bob McDonald, who's led P&G MORE

    - May 8, 2013 3:38 PM ET
  • J.C. Penney's friend list grows by one

    J.C. Penney has few friends on Wall Street, but Thursday, the troubled retailer gained one more.

    BTIG analyst William Frohnhoefer issued a "buy" rating, making him one of the few analysts to recommend purchasing J.C. Penney's stock.

    Frohnhoefer also set a price target of $22 per share. That's more than 40% higher from where J.C. Penney's (JCP) stock is currently trading. Early Thursday, shares slid 1% to $15.53.

    The call is a rare MORE

    - Mar 14, 2013 11:44 AM ET
  • Herbalife strengthens ties with Icahn

    Shares of Herbalife jumped Thursday after the nutritional supplement company said billionaire investor Carl Icahn will be allowed to nominate two board members.

    Herbalife (HLF) shares ended the day up 7%. The stock was briefly halted on the news.

    Under the terms of a deal with Icahn's holding company, Herbalife agreed to have Icahn nominate two members to the company's board, which will grow to 11 directors. The new board members will MORE

    - Feb 28, 2013 4:39 PM ET
  • Sears' stock sinks on poor results

    It's a tough week to be a retailer in search of customers. First, the shares of J.C. Penney (JCP) cratered after the Ron Johnson-led retailer reported abysmal fourth-quarter numbers Wednesday night.

    Next up: Sears (SHLD). The iconic retailer can't turn a profit or get customers excited about its merchandise or Kmart's. After reporting yet another quarter of steep losses early Thursday, Sears' stock dropped nearly 5%.

    Releasing results so close to JCPenney at least makes MORE

    - Feb 28, 2013 3:15 PM ET
Fear & Greed
Sponsored by

To view my watchlist

Not a member yet?

Sign up now for a free account
Stupid Stock Move of the Day
#StupidStock Move of the Day! Yes. Before 10. $CSCO up on buy rating? Sure, it's safe dividend tech. But isn't Heartbleed router news bad?
Powered by VIP.